Skip to main content
. 2023 May 23;44(31):2930–2943. doi: 10.1093/eurheartj/ehad283

Structured Graphical Abstract.

Structured Graphical Abstract

The clinical benefits of dapagliflozin vs. placebo exhibit consistent safety and efficacy across a wide range of background diuretic use. Treatment with dapagliflozin reduces loop diuretic requirement over time. CI, confidence interval; HR, hazard ratio.